Amphastar Pharmaceuticals (AMPH) Earnings Date, Estimates & Call Transcripts → Write this ticker symbol down… (From StocksToTrade) (Ad) Free AMPH Stock Alerts $41.98 -1.28 (-2.96%) (As of 05/28/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 8) $0.93 Beat By $0.20 Consensus EPS (May. 8) $0.73 Get Amphastar Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for AMPH and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAMPH Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AMPH Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad American AlternativeYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW Amphastar Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241$0.72$0.72$0.72Q2 20241$0.73$0.73$0.73Q3 20241$0.96$0.96$0.96Q4 20241$1.02$1.02$1.02FY 20244$3.43$3.43$3.43AMPH Earnings Date and InformationAmphastar Pharmaceuticals last posted its quarterly earnings results on May 8th, 2024. The reported $0.93 earnings per share for the quarter, topping analysts' consensus estimates of $0.73 by $0.20. The business earned $171.84 million during the quarter, compared to analyst estimates of $171.13 million. Amphastar Pharmaceuticals has generated $2.89 earnings per share over the last year ($2.89 diluted earnings per share) and currently has a price-to-earnings ratio of 14.5. Earnings for Amphastar Pharmaceuticals are expected to grow by 15.28% in the coming year, from $3.60 to $4.15 per share. Amphastar Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Amphastar Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024(Estimated)------- 5/8/2024Q1 2024$0.73$0.93+$0.20$1.05$171.13 million$171.84 million2/28/2024Q4 2023$0.84$0.81($0.03)$0.94$174.90 million$178.11 million11/8/2023Q3 2023$0.67$1.08+$0.41$1.25$170.65 million$180.56 million8/8/2023Q2 2023$0.52$0.58+$0.06$0.67$137.20 million$145.71 million5/9/2023Q1 2023$0.40$0.52+$0.12$0.54$130.50 million$140.02 million2/28/2023Q4 2022$0.34$0.67+$0.33$0.68$126.43 million$135.02 million Get the Latest News and Ratings for AMPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amphastar Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/7/2022Q3 2022$0.32$0.32-$0.34$126.20 million$120.13 million8/8/2022Q2 2022$0.30$0.33+$0.03$0.33$118.17 million$123.47 million 5/9/2022Q1 2022$0.33$0.47+$0.14$0.47$110.60 million$120.37 million 3/10/2022Q4 2021$0.38$0.42+$0.04$0.45$111.38 million$120.89 million 11/8/2021Q3 2021$0.24$0.46+$0.22$0.33$103.00 million$112.20 million 8/8/2021Q2 2021$0.21$0.21-$0.26$101.38 million$101.66 million 5/6/2021Q1 2021$0.19$0.27+$0.08$0.44$97.12 million$103.02 million 3/14/2021Q4 2020$0.14$0.16+$0.02$0.45$89.29 million$95.92 million 11/11/2020Q3 2020$0.14$0.15+$0.01$0.10$90.81 million$83.43 million 8/6/2020Q2 2020$0.11$0.16+$0.05$0.32$84.30 million$85.81 million 5/7/2020Q1 2020$0.09$0.17+$0.08$0.26$81.80 million$84.69 million 3/12/2020Q4 2019$0.05$0.07+$0.02$0.16$80.28 million$83.38 million 11/7/2019Q3$0.08$0.10+$0.02$0.17$78.53 million$80.14 million 8/7/2019Q2 2019$0.03$0.08+$0.05($0.80)$78.90 million$79.00 million Amphastar Pharmaceuticals Earnings - Frequently Asked Questions When is Amphastar Pharmaceuticals's earnings date? Amphastar Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on AMPH's earnings history. Did Amphastar Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Amphastar Pharmaceuticals (NASDAQ:AMPH) reported $0.93 earnings per share (EPS) to beat the analysts' consensus estimate of $0.73 by $0.20. Learn more on analysts' earnings estimate vs. AMPH's actual earnings. How much revenue does Amphastar Pharmaceuticals generate each year? Amphastar Pharmaceuticals (NASDAQ:AMPH) has a recorded annual revenue of $644.40 million. How much profit does Amphastar Pharmaceuticals generate each year? Amphastar Pharmaceuticals (NASDAQ:AMPH) has a recorded net income of $137.54 million. AMPH has generated $2.89 earnings per share over the last four quarters. What is Amphastar Pharmaceuticals's price-to-earnings ratio? Amphastar Pharmaceuticals (NASDAQ:AMPH) has a trailing price-to-earnings ratio of 14.52 and a forward price-to-earnings ratio of 11.66. The price/earnings-to-growth ratio is 0.89. What is Amphastar Pharmaceuticals's EPS forecast for next year? Amphastar Pharmaceuticals's earnings are expected to grow from $3.60 per share to $4.15 per share in the next year, which is a 15.28% increase. More Earnings Resources from MarketBeat Related Companies: Protagonist Therapeutics Earnings Results Syndax Pharmaceuticals Earnings Results Phibro Animal Health Earnings Results Calliditas Therapeutics AB (publ) Earnings Results Esperion Therapeutics Earnings Results Enanta Pharmaceuticals Earnings Results Elanco Animal Health Earnings Results Ascendis Pharma A/S Earnings Results Legend Biotech Earnings Results Cerevel Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: TD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's Earnings This page (NASDAQ:AMPH) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amphastar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.